Cell and Gene Therapy Market Outlook Highlights The Next Major Growth Opportunities
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Cell and Gene Therapy Market Growth Potential: How Will Market Size Change Through 2030?
Over the past few years, the cell and gene therapy market has experienced remarkable expansion. Projections indicate that its value will increase from $21.33 billion in 2025 to $26.21 billion in 2026, reflecting a compound annual growth rate (CAGR) of 22.9%. Several factors have driven this historical growth, including the restricted accessibility of cell and gene therapies, a continued dependence on traditional treatment approaches, the elevated cost of earlier therapy versions, a rising prevalence of cancer and neurological conditions, and a shortage of dedicated treatment facilities.
The cell and gene therapy market is projected to undergo rapid expansion over the upcoming years. By 2030, it is forecasted to reach $60.58 billion, advancing at a compound annual growth rate (CAGR) of 23.3%. Several factors are expected to fuel this growth during the forecast period, such as the creation of cutting-edge CAR-T and genome editing therapies, the broadening of clinical trials and research initiatives, a growing focus on personalized medicine, enhanced governmental backing and funding for rare disease treatments, and the incorporation of digital platforms for treatment monitoring and patient management. Key developments anticipated in this period encompass the rising implementation of CAR-T and stem cell therapies, increased funding for gene therapy targeting oncology and rare conditions, a surge in tailored and cell-based treatment approaches, the growth of hospitals and ambulatory surgical centers providing advanced therapies, and the adoption of genome editing and viral vector technologies across therapeutic applications.
Download A Free Sample Report For Comprehensive Market Insights:
Cell and Gene Therapy Market Development Factors: Which Trends Are Supporting Demand?
An increasing volume of active clinical trials is anticipated to drive expansion in the cell and gene therapy market moving forward. These trials involve research studies carried out with human volunteers to assess the safety and effectiveness of novel medical treatments, interventions, or diagnostic methods. Clinical trials are essential for the progress and refinement of cell and gene therapy, offering a secure and regulated setting where new therapies can be tested and data regarding their safety and efficacy can be gathered. For example, in December 2024, the Association of the British Pharmaceutical Industry (ABPI), a UK-based organization, reported that the number of pharmaceutical industry trials initiated in the UK grew for the second consecutive year, climbing from 411 in 2022 to 426 in 2023. Consequently, the rising count of ongoing clinical trials is fueling growth in the cell and gene therapy market.
Cell and Gene Therapy Market Segment Performance And Strategic Opportunities
The cell and gene therapy market covered in this report is segmented –
1) By Product: Cell Therapy, Gene Therapy
2) By Application: Oncology, Neurological Disorders, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Cancer Care Centers, Wound Care Centers, Other End-Users
Subsegments:
1) By Cell Therapy: Autologous Cell Therapy, Allogeneic Cell Therapy, Stem Cell Therapy, CAR-T Cell Therapy
2) By Gene Therapy: Viral Vector-Based Gene Therapy, Non-Viral Vector-Based Gene Therapy, Genome Editing Technologies, Antisense Oligonucleotide Therapy
Cell and Gene Therapy Market Transformation Trends: Which Innovations Are Driving Change?
Major players in the cell and gene therapy sector are intensifying their efforts to develop agnostic systems as a strategy for securing a competitive advantage. These agnostic systems are designed to integrate seamlessly with diverse cell and gene therapy (CGT) software platforms, alongside various biopharmaceutical or provider-facing systems. A notable example occurred in April 2023, when AmerisourceBergen, a healthcare company based in the United States, introduced the Cell and Gene Therapy Integration Hub. This platform-agnostic solution was created to enhance connectivity throughout the CGT treatment process, ultimately improving experiences for both patients and providers. Driven by the company’s customer relationship management system, the hub accelerates the benefits investigation process, delivers real-time updates on therapy development and transportation, and supports the coordination of patient care.
Cell and Gene Therapy Market Key Players: Which Companies Shape Industry Competition?
Major companies operating in the cell and gene therapy market are Biogen Inc., Novartis AG, Gilead Sciences, Ionis Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., ArrowHead Pharmaceuticals Inc., Spark Therapeutics, Bluebird Bio Inc., RegenexBio, Mesoblast Limited, Stempeutics Research Pvt. Ltd., EdiGene Inc., Takara Bio, Oxford Biomedica plc, Merck, GenScript, Cellular Biomedicine Group, inStem, Bristol-Myers Squibb, Amgen, Pfizer, Kite Pharma, Freeline Therapeutics, PsiOxus Therapeutics, Herantis Pharma Plc, AstraZeneca
Access The Complete Cell and Gene Therapy Market Report:
Cell and Gene Therapy Market Geographic Landscape: Which Region Dominates Industry Growth?
North America was the largest region in the cell and gene therapy market in 2025. The regions covered in the cell and gene therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
